A Phase 1b/2a Trial Adding X4P-001 in Patients Receiving Nivolumab for Treatment of Advanced Clear Cell Renal Cell Carcinoma

Type of Cancer
Genito-Urinary

Sponsor
X4 Pharmaceuticals

Protocol Number
X4P-001-RCCB

To Learn More Call
201-510-0910